Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Inicio inmediato de los anticonceptivos hormonales para la anticoncepción

Información

DOI:
https://doi.org/10.1002/14651858.CD006260.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 diciembre 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Regulación de la fertilidad

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Laureen M Lopez

    Correspondencia a: Clinical Sciences, FHI 360, Research Triangle Park, USA

    [email protected]

  • Sara J Newmann

    Obstetrics and Gynecology and Reproductive Sciences, University of California, San Francisco General Hospital, San Francisco, USA

  • David A Grimes

    Obstetrics and Gynecology, University of North Carolina, School of Medicine, Chapel Hill, USA

  • Kavita Nanda

    Clinical Sciences, FHI, Research Triangle Park, USA

  • Kenneth F Schulz

    Quantitative Sciences, FHI 360 and UNC School of Medicine, Research Triangle Park, USA

Contributions of authors

S Newmann and D Grimes developed the concept. S Newmann drafted the protocol, reviewed the initial searches, and began data abstraction. L Lopez completed the searches for the review, did the primary data abstraction, and drafted the review; she also updated the review in 2010 and 2012. D Grimes did the second data extraction and edited and advised on the review. K Nanda edited and advised on the review. K Schulz provided statistical expertise and edited the review.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • US Agency for International Development, USA.

  • National Institute of Child Health and Human Development, USA.

Declarations of interest

DA Grimes has consulted with the pharmaceutical companies Bayer Healthcare Pharmaceuticals and Merck & Co, Inc.

K Nanda is the principal investigator of a trial on this subject; the results may be included in an update.

Acknowledgements

From FHI 360: Carol Manion assisted with literature searches (2007 and 2010); Laurie Stockton reviewed studies for eligibility and searched for additional study information (2012); John Stanback helped update the Background section (2012).

Version history

Published

Title

Stage

Authors

Version

2012 Dec 12

Immediate start of hormonal contraceptives for contraception

Review

Laureen M Lopez, Sara J Newmann, David A Grimes, Kavita Nanda, Kenneth F Schulz

https://doi.org/10.1002/14651858.CD006260.pub3

2008 Apr 23

Immediate start of hormonal contraceptives for contraception

Review

Laureen M Lopez, Sara J Newmann, David A Grimes, Kavita Nanda, Kenneth F Schulz

https://doi.org/10.1002/14651858.CD006260.pub2

2006 Oct 18

Immediate start of combined hormonal contraceptives for contraception

Protocol

Sara J Newmann, David A Grimes, Kavita Nanda, Laureen M Lopez, Kenneth F Schulz

https://doi.org/10.1002/14651858.CD006260

Differences between protocol and review

In 2012, we added to Types of studies: Treatment duration had to be at least three cycles or 84 days.